Vir Biotechnology Inc (VIR)

09:15 AM

Vir Biotechnology Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program - Business Wire

09:15 AM

04:56 AM

EMA grants orphan drug status to Vir Biotech hepatitis treatments - Investing.com

04:56 AM

04:08 AM

Vir Biotechnology (VIR) Receives Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta from European Medicines Agency - StreetInsider.com

04:08 AM

04:05 AM

Vir Biotechnology Secures Key EU Orphan Drug Status for Hepatitis Delta Treatment | VIR Stock News - StockTitan

04:05 AM

07:06 AM

Vir Biotechnology Announces Positive End-of-Treatment Results for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B from the MARCH Study at AASLD the Liver Meeting - Marketscreener.com

07:06 AM

Nov 16, 2024

Vir Biotechnology (NASDAQ:VIR) Shares Down 7.4%Here's Why - MarketBeat

Nov 16, 2024

Nov 15, 2024

(VIR) Proactive Strategies - Stock Traders Daily

Nov 15, 2024

Nov 15, 2024

What's Going On With Liver Disease Focused Vir Biotechnology Stock Is Friday? - Yahoo Finance

Nov 15, 2024

Nov 15, 2024

Promising hepatitis B treatment data presented by Vir Biotechnology - Investing.com

Nov 15, 2024

Nov 15, 2024

Vir Biotechnology Inc. (VIR) Announces Positive End-of-Treatment Results for Tobevibart and Elebsiran Combinations - StreetInsider.com

Nov 15, 2024

Nov 15, 2024

Vir Biotechnology Announces Positive End-of-Treatment Results for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B from the MARCH Study at AASLD The Liver Meeting - Business Wire

Nov 15, 2024

Nov 13, 2024

Baillie Gifford & Co. Reduces Position in Vir Biotechnology, Inc. (NASDAQ:VIR) - MarketBeat

Nov 13, 2024

Nov 08, 2024

Vir Biotechnology's EVP sells shares worth $44,453 - Investing.com India

Nov 08, 2024

Nov 07, 2024

Vir Biotechnology's EVP sells shares worth $44,453 By Investing.com - Investing.com UK

Nov 07, 2024

Nov 06, 2024

Leerink Partnrs Has Negative Outlook of VIR FY2024 Earnings - MarketBeat

Nov 06, 2024

Nov 06, 2024

HC Wainwright Expects Lower Earnings for Vir Biotechnology - MarketBeat

Nov 06, 2024

Nov 06, 2024

Vir Biotechnology, Inc. (NASDAQ:VIR) Q3 2024 Earnings Call Transcript - MSN

Nov 06, 2024

Nov 05, 2024

Vir Biotechnology's Refocused Pipeline: Hepatitis And Oncology Could Still Pay Off (NASDAQ:VIR) - Seeking Alpha

Nov 05, 2024

Nov 05, 2024

VIR Biotechnology's SWOT analysis: stock poised for growth amid challenges - Investing.com India

Nov 05, 2024

Nov 05, 2024

VIR Biotechnology's SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com Nigeria

Nov 05, 2024

Nov 05, 2024

Vir Biotechnology EVP vanina de Verneuil sells $32,332 in shares - Investing.com

Nov 05, 2024

Nov 05, 2024

Trading (VIR) With Integrated Risk Controls - Stock Traders Daily

Nov 05, 2024

Nov 04, 2024

HC Wainwright Reiterates "Buy" Rating for Vir Biotechnology (NASDAQ:VIR) - MarketBeat

Nov 04, 2024

Nov 04, 2024

Vir Biotechnology (NASDAQ:VIR) Price Target Cut to $26.00 by Analysts at Barclays - MarketBeat

Nov 04, 2024

Nov 04, 2024

Earnings Update: Vir Biotechnology, Inc. (NASDAQ:VIR) Just Reported And Analysts Are Trimming Their Forecasts - Simply Wall St

Nov 04, 2024

Nov 04, 2024

Analysts Have Lowered Expectations For Vir Biotechnology, Inc. (NASDAQ:VIR) After Its Latest Results - Yahoo Finance

Nov 04, 2024

Nov 02, 2024

Vir Biotechnology Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 02, 2024

Nov 02, 2024

Vir Biotechnology, Inc. (VIR) Reports Q3 Loss, Lags Revenue Estimates - MSN

Nov 02, 2024

Nov 01, 2024

Vir Biotechnology Inc (VIR) Q3 2024 Earnings Call Highlights: Strategic Restructuring and ... By GuruFocus - Investing.com Canada

Nov 01, 2024

Nov 01, 2024

Vir Biotechnology (NASDAQ:VIR) Posts Quarterly Earnings Results, Misses Estimates By $0.51 EPS - MarketBeat

Nov 01, 2024

Nov 01, 2024

Vir Biotechnology Inc (VIR) Q3 2024 Earnings Call Highlights: Strategic Restructuring and ... - Yahoo Finance

Nov 01, 2024

Nov 01, 2024

Vir Biotechnology Q3 2024 Earnings Preview - MSN

Nov 01, 2024

Nov 01, 2024

Earnings call: Vir Biotechnology advances with Sanofi deal, hepatitis trials By Investing.com - Investing.com South Africa

Nov 01, 2024

Nov 01, 2024

Stock Traders Buy High Volume of Call Options on Vir Biotechnology (NASDAQ:VIR) - MarketBeat

Nov 01, 2024

Nov 01, 2024

Earnings call: Vir Biotechnology advances with Sanofi deal, hepatitis trials - Investing.com

Nov 01, 2024

Nov 01, 2024

Vir Biotechnology (NASDAQ:VIR) Shares Gap Down on Disappointing Earnings - MarketBeat

Nov 01, 2024

Nov 01, 2024

Vir Biotechnology (NASDAQ:VIR) shareholders have endured a 76% loss from investing in the stock three years ago - Yahoo Finance

Nov 01, 2024

Nov 01, 2024

Vir Biotechnology (NASDAQ:VIR) Earns Buy Rating from Needham & Company LLC - MarketBeat

Nov 01, 2024

Nov 01, 2024

Vir Biotechnology Reports Q3 2024 Financial Results - TipRanks

Nov 01, 2024

Oct 31, 2024

Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update - BioSpace

Oct 31, 2024

Oct 31, 2024

Vir Biotechnology Inc. (VIR) Misses Q3 EPS by 51c - StreetInsider.com

Oct 31, 2024

Oct 25, 2024

Trend Tracker for (VIR) - Stock Traders Daily

Oct 25, 2024

Oct 24, 2024

Vir Biotechnology (VIR) to Release Earnings on Thursday - MarketBeat

Oct 24, 2024

Oct 18, 2024

State Street Corp's Strategic Acquisition in Vir Biotechnology Inc - Yahoo Finance

Oct 18, 2024

Oct 18, 2024

State Street Corp's Strategic Acquisition in Vir Biotechnology I - GuruFocus.com

Oct 18, 2024

Oct 17, 2024

Vir Biotechnology to Provide Business Update and Report Third Quarter 2024 Financial Results on October 31, 2024 - BioSpace

Oct 17, 2024

Oct 16, 2024

Was there any good news for Vir Biotechnology Inc (VIR) stock in the last session? - US Post News

Oct 16, 2024

Oct 16, 2024

Possible Bearish Signals With Vir Biotechnology Insiders Disposing Stock - Simply Wall St

Oct 16, 2024

Oct 15, 2024

Vir Biotechnology Announces Clinical Advances Across Hepatitis Delta and Hepatitis B Programs at AASLD’s The Liver Meeting® 2024 - BioSpace

Oct 15, 2024

Oct 15, 2024

Vir Biotechnology to present hepatitis trial findings - Investing.com

Oct 15, 2024

Oct 15, 2024

Vir Biotechnology to present hepatitis trial findings By Investing.com - Investing.com South Africa

Oct 15, 2024